{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.208","meta":{"versionId":"4","lastUpdated":"2018-04-20T12:05:19.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.208","version":"Draft","name":"Lapatinib","status":"draft","date":"2018-04-20T12:05:19-04:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"672147","display":"lapatinib 250 MG"},{"code":"672149","display":"lapatinib 250 MG Oral Tablet"},{"code":"672150","display":"lapatinib 250 MG [Tykerb]"},{"code":"672151","display":"lapatinib Oral Tablet [Tykerb]"},{"code":"672152","display":"lapatinib 250 MG Oral Tablet [Tykerb]"}]}]}}